Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ras Peptide-Pulsed DC Vaccine +/- IL-2 in Colorectal Cancer
NCT00019591Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 1999
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ras peptide-pulsed dendritic cell vaccine in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Mar 1999; status: completed.
02
Drugs
ras peptide-pulsed dendritic cell vaccine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00019591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019591.